肺がん手術世界市場の発展状況と動向 2024-2030
英文タイトル: Global Lung Cancer Surgery Market Insights, Forecast to 2030
販売価格(消費税別)
個人版
マルチユーザー版
企業版
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。
※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。
概要
本報告書は肺がん手術市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは肺がん手術の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。
世界の肺がん手術市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは肺がん手術のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に肺がん手術市場を分類しています。本研究に含まれる主な企業は:Accuray、Angiodynamics、Ethicon、Intuitive Surgical、Olympus、Teleflex、Ackermann Instrumente、Karl Storz、Scanlan International、Trokamed
地域別市場区分、地域別分析は以下の通り:
アメリカとカナダ
中国
アジア
ヨーロッパ
中東、アフリカ、ラテンアメリカ
タイプ別市場セグメント:
Surgical Instruments
Monitoring And Visualization System
用途別の市場セグメント:
Lobectomy
Removal Of Sleeve
Regional Excision
Lung Removed All
Minimally Invasive Surgery
本レポートの詳細内容
世界の肺がん手術市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、肺がん手術タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の肺がん手術収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の肺がん手術市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、肺がん手術市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。
肺がん手術のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。
章の概要
第1章:肺がん手術のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント(製品タイプ、用途など)のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。(2019~2030)
第2章:肺がん手術の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。(2019~2030)
第3章肺がん手術企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。(2019~2030)
第4章:各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(2019~2024)
第5章:肺がん手術の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。(2019~2030)
第6章:北米(米国、カナダ)のタイプ別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第7章:ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第8章:中国の種類別、および用途別、各セグメントの収益。(2019~2030)
第9章アジア(中国を除く)の種類別、用途別、地域別、セグメントごとの収益。(2019~2030)
第10章:中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第11章:肺がん手術の主要企業の概要を提供し、製品の説明と仕様、肺がん手術の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。(2019~2024)
第12章:アナリストの見解/結論
概要
Lung adenocarcinoma is a type of lung cancer and belongs to non-small cell carcinoma. Market Analysis and Insights: Global Lung Cancer Surgery Market The global Lung Cancer Surgery market is projected to grow from US$ 22030 million in 2024 to US$ 30200 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period. According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment. Report Covers: This report presents an overview of global market for Lung Cancer Surgery market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. This report researches the key producers of Lung Cancer Surgery, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Lung Cancer Surgery, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries. This report focuses on the Lung Cancer Surgery revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Lung Cancer Surgery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Lung Cancer Surgery revenue, projected growth trends, production technology, application and end-user industry. Descriptive company profiles of the major global players, including Accuray, Angiodynamics, Ethicon, Intuitive Surgical, Olympus, Teleflex, Ackermann Instrumente, Karl Storz and Scanlan International, etc. Market Segmentation By Company Accuray Angiodynamics Ethicon Intuitive Surgical Olympus Teleflex Ackermann Instrumente Karl Storz Scanlan International Trokamed Segment by Type Surgical Instruments Monitoring And Visualization System Segment by Application Lobectomy Removal Of Sleeve Regional Excision Lung Removed All Minimally Invasive Surgery By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe China Asia (excluding China) Japan South Korea China Taiwan Southeast Asia India Latin America, Middle East & Africa Brazil Mexico Turkey Israel GCC Countries Chapter Outline Chapter Outline Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 2: Revenue of Lung Cancer Surgery in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 3: Detailed analysis of Lung Cancer Surgery companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment. Chapter 7: Europe by Type, by Application and by country, revenue for each segment. Chapter 8: China by Type, and by Application, revenue for each segment. Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment. Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment. Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lung Cancer Surgery revenue, gross margin, and recent development, etc. Chapter 12: Analyst's Viewpoints/Conclusions
総目録
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer Surgery Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Surgical Instruments
1.2.3 Monitoring And Visualization System
1.3 Market by Application
1.3.1 Global Lung Cancer Surgery Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Lobectomy
1.3.3 Removal Of Sleeve
1.3.4 Regional Excision
1.3.5 Lung Removed All
1.3.6 Minimally Invasive Surgery
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lung Cancer Surgery Market Perspective (2019-2030)
2.2 Global Lung Cancer Surgery Growth Trends by Region
2.2.1 Lung Cancer Surgery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Lung Cancer Surgery Historic Market Size by Region (2019-2024)
2.2.3 Lung Cancer Surgery Forecasted Market Size by Region (2025-2030)
2.3 Lung Cancer Surgery Market Dynamics
2.3.1 Lung Cancer Surgery Industry Trends
2.3.2 Lung Cancer Surgery Market Drivers
2.3.3 Lung Cancer Surgery Market Challenges
2.3.4 Lung Cancer Surgery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Lung Cancer Surgery by Players
3.1.1 Global Lung Cancer Surgery Revenue by Players (2019-2024)
3.1.2 Global Lung Cancer Surgery Revenue Market Share by Players (2019-2024)
3.2 Global Lung Cancer Surgery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Lung Cancer Surgery, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Lung Cancer Surgery Market Concentration Ratio
3.4.1 Global Lung Cancer Surgery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Surgery Revenue in 2023
3.5 Global Key Players of Lung Cancer Surgery Head office and Area Served
3.6 Global Key Players of Lung Cancer Surgery, Product and Application
3.7 Global Key Players of Lung Cancer Surgery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Lung Cancer Surgery Breakdown Data by Type
4.1 Global Lung Cancer Surgery Historic Market Size by Type (2019-2024)
4.2 Global Lung Cancer Surgery Forecasted Market Size by Type (2025-2030)
5 Lung Cancer Surgery Breakdown Data by Application
5.1 Global Lung Cancer Surgery Historic Market Size by Application (2019-2024)
5.2 Global Lung Cancer Surgery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Lung Cancer Surgery Market Size (2019-2030)
6.2 North America Lung Cancer Surgery Market Size by Type
6.2.1 North America Lung Cancer Surgery Market Size by Type (2019-2024)
6.2.2 North America Lung Cancer Surgery Market Size by Type (2025-2030)
6.2.3 North America Lung Cancer Surgery Market Share by Type (2019-2030)
6.3 North America Lung Cancer Surgery Market Size by Application
6.3.1 North America Lung Cancer Surgery Market Size by Application (2019-2024)
6.3.2 North America Lung Cancer Surgery Market Size by Application (2025-2030)
6.3.3 North America Lung Cancer Surgery Market Share by Application (2019-2030)
6.4 North America Lung Cancer Surgery Market Size by Country
6.4.1 North America Lung Cancer Surgery Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Lung Cancer Surgery Market Size by Country (2019-2024)
6.4.3 North America Lung Cancer Surgery Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Lung Cancer Surgery Market Size (2019-2030)
7.2 Europe Lung Cancer Surgery Market Size by Type
7.2.1 Europe Lung Cancer Surgery Market Size by Type (2019-2024)
7.2.2 Europe Lung Cancer Surgery Market Size by Type (2025-2030)
7.2.3 Europe Lung Cancer Surgery Market Share by Type (2019-2030)
7.3 Europe Lung Cancer Surgery Market Size by Application
7.3.1 Europe Lung Cancer Surgery Market Size by Application (2019-2024)
7.3.2 Europe Lung Cancer Surgery Market Size by Application (2025-2030)
7.3.3 Europe Lung Cancer Surgery Market Share by Application (2019-2030)
7.4 Europe Lung Cancer Surgery Market Size by Country
7.4.1 Europe Lung Cancer Surgery Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Lung Cancer Surgery Market Size by Country (2019-2024)
7.4.3 Europe Lung Cancer Surgery Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Lung Cancer Surgery Market Size (2019-2030)
8.2 China Lung Cancer Surgery Market Size by Type
8.2.1 China Lung Cancer Surgery Market Size by Type (2019-2024)
8.2.2 China Lung Cancer Surgery Market Size by Type (2025-2030)
8.2.3 China Lung Cancer Surgery Market Share by Type (2019-2030)
8.3 China Lung Cancer Surgery Market Size by Application
8.3.1 China Lung Cancer Surgery Market Size by Application (2019-2024)
8.3.2 China Lung Cancer Surgery Market Size by Application (2025-2030)
8.3.3 China Lung Cancer Surgery Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Lung Cancer Surgery Market Size (2019-2030)
9.2 Asia Lung Cancer Surgery Market Size by Type
9.2.1 Asia Lung Cancer Surgery Market Size by Type (2019-2024)
9.2.2 Asia Lung Cancer Surgery Market Size by Type (2025-2030)
9.2.3 Asia Lung Cancer Surgery Market Share by Type (2019-2030)
9.3 Asia Lung Cancer Surgery Market Size by Application
9.3.1 Asia Lung Cancer Surgery Market Size by Application (2019-2024)
9.3.2 Asia Lung Cancer Surgery Market Size by Application (2025-2030)
9.3.3 Asia Lung Cancer Surgery Market Share by Application (2019-2030)
9.4 Asia Lung Cancer Surgery Market Size by Region
9.4.1 Asia Lung Cancer Surgery Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Lung Cancer Surgery Market Size by Region (2019-2024)
9.4.3 Asia Lung Cancer Surgery Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Lung Cancer Surgery Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Lung Cancer Surgery Market Size by Type
10.2.1 Middle East, Africa, and Latin America Lung Cancer Surgery Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Lung Cancer Surgery Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Lung Cancer Surgery Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Lung Cancer Surgery Market Size by Application
10.3.1 Middle East, Africa, and Latin America Lung Cancer Surgery Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Lung Cancer Surgery Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Lung Cancer Surgery Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Lung Cancer Surgery Market Size by Country
10.4.1 Middle East, Africa, and Latin America Lung Cancer Surgery Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Lung Cancer Surgery Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Lung Cancer Surgery Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Accuray
11.1.1 Accuray Company Details
11.1.2 Accuray Business Overview
11.1.3 Accuray Lung Cancer Surgery Introduction
11.1.4 Accuray Revenue in Lung Cancer Surgery Business (2019-2024)
11.1.5 Accuray Recent Developments
11.2 Angiodynamics
11.2.1 Angiodynamics Company Details
11.2.2 Angiodynamics Business Overview
11.2.3 Angiodynamics Lung Cancer Surgery Introduction
11.2.4 Angiodynamics Revenue in Lung Cancer Surgery Business (2019-2024)
11.2.5 Angiodynamics Recent Developments
11.3 Ethicon
11.3.1 Ethicon Company Details
11.3.2 Ethicon Business Overview
11.3.3 Ethicon Lung Cancer Surgery Introduction
11.3.4 Ethicon Revenue in Lung Cancer Surgery Business (2019-2024)
11.3.5 Ethicon Recent Developments
11.4 Intuitive Surgical
11.4.1 Intuitive Surgical Company Details
11.4.2 Intuitive Surgical Business Overview
11.4.3 Intuitive Surgical Lung Cancer Surgery Introduction
11.4.4 Intuitive Surgical Revenue in Lung Cancer Surgery Business (2019-2024)
11.4.5 Intuitive Surgical Recent Developments
11.5 Olympus
11.5.1 Olympus Company Details
11.5.2 Olympus Business Overview
11.5.3 Olympus Lung Cancer Surgery Introduction
11.5.4 Olympus Revenue in Lung Cancer Surgery Business (2019-2024)
11.5.5 Olympus Recent Developments
11.6 Teleflex
11.6.1 Teleflex Company Details
11.6.2 Teleflex Business Overview
11.6.3 Teleflex Lung Cancer Surgery Introduction
11.6.4 Teleflex Revenue in Lung Cancer Surgery Business (2019-2024)
11.6.5 Teleflex Recent Developments
11.7 Ackermann Instrumente
11.7.1 Ackermann Instrumente Company Details
11.7.2 Ackermann Instrumente Business Overview
11.7.3 Ackermann Instrumente Lung Cancer Surgery Introduction
11.7.4 Ackermann Instrumente Revenue in Lung Cancer Surgery Business (2019-2024)
11.7.5 Ackermann Instrumente Recent Developments
11.8 Karl Storz
11.8.1 Karl Storz Company Details
11.8.2 Karl Storz Business Overview
11.8.3 Karl Storz Lung Cancer Surgery Introduction
11.8.4 Karl Storz Revenue in Lung Cancer Surgery Business (2019-2024)
11.8.5 Karl Storz Recent Developments
11.9 Scanlan International
11.9.1 Scanlan International Company Details
11.9.2 Scanlan International Business Overview
11.9.3 Scanlan International Lung Cancer Surgery Introduction
11.9.4 Scanlan International Revenue in Lung Cancer Surgery Business (2019-2024)
11.9.5 Scanlan International Recent Developments
11.10 Trokamed
11.10.1 Trokamed Company Details
11.10.2 Trokamed Business Overview
11.10.3 Trokamed Lung Cancer Surgery Introduction
11.10.4 Trokamed Revenue in Lung Cancer Surgery Business (2019-2024)
11.10.5 Trokamed Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
表と図のリスト
List of Tables Table 1. Global Lung Cancer Surgery Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030 Table 2. Key Players of Surgical Instruments Table 3. Key Players of Monitoring And Visualization System Table 4. Global Lung Cancer Surgery Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030 Table 5. Global Lung Cancer Surgery Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 6. Global Lung Cancer Surgery Market Size by Region (2019-2024) & (US$ Million) Table 7. Global Lung Cancer Surgery Market Share by Region (2019-2024) Table 8. Global Lung Cancer Surgery Forecasted Market Size by Region (2025-2030) & (US$ Million) Table 9. Global Lung Cancer Surgery Market Share by Region (2025-2030) Table 10. Lung Cancer Surgery Market Trends Table 11. Lung Cancer Surgery Market Drivers Table 12. Lung Cancer Surgery Market Challenges Table 13. Lung Cancer Surgery Market Restraints Table 14. Global Lung Cancer Surgery Revenue by Players (2019-2024) & (US$ Million) Table 15. Global Lung Cancer Surgery Revenue Share by Players (2019-2024) Table 16. Global Top Lung Cancer Surgery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Surgery as of 2023) Table 17. Global Lung Cancer Surgery Industry Ranking 2022 VS 2023 VS 2024 Table 18. Global 5 Largest Players Market Share by Lung Cancer Surgery Revenue (CR5 and HHI) & (2019-2024) Table 19. Global Key Players of Lung Cancer Surgery, Headquarters and Area Served Table 20. Global Key Players of Lung Cancer Surgery, Product and Application Table 21. Global Key Players of Lung Cancer Surgery, Product and Application Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Lung Cancer Surgery Market Size by Type (2019-2024) & (US$ Million) Table 24. Global Lung Cancer Surgery Revenue Market Share by Type (2019-2024) Table 25. Global Lung Cancer Surgery Forecasted Market Size by Type (2025-2030) & (US$ Million) Table 26. Global Lung Cancer Surgery Revenue Market Share by Type (2025-2030) Table 27. Global Lung Cancer Surgery Market Size by Application (2019-2024) & (US$ Million) Table 28. Global Lung Cancer Surgery Revenue Share by Application (2019-2024) Table 29. Global Lung Cancer Surgery Forecasted Market Size by Application (2025-2030) & (US$ Million) Table 30. Global Lung Cancer Surgery Revenue Share by Application (2025-2030) Table 31. North America Lung Cancer Surgery Market Size by Type (2019-2024) & (US$ Million) Table 32. North America Lung Cancer Surgery Market Size by Type (2025-2030) & (US$ Million) Table 33. North America Lung Cancer Surgery Market Size by Application (2019-2024) & (US$ Million) Table 34. North America Lung Cancer Surgery Market Size by Application (2025-2030) & (US$ Million) Table 35. North America Lung Cancer Surgery Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 36. North America Lung Cancer Surgery Market Size by Country (2019-2024) & (US$ Million) Table 37. North America Lung Cancer Surgery Market Size by Country (2025-2030) & (US$ Million) Table 38. Europe Lung Cancer Surgery Market Size by Type (2019-2024) & (US$ Million) Table 39. Europe Lung Cancer Surgery Market Size by Type (2025-2030) & (US$ Million) Table 40. Europe Lung Cancer Surgery Market Size by Application (2019-2024) & (US$ Million) Table 41. Europe Lung Cancer Surgery Market Size by Application (2025-2030) & (US$ Million) Table 42. Europe Lung Cancer Surgery Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 43. Europe Lung Cancer Surgery Market Size by Country (2019-2024) & (US$ Million) Table 44. Europe Lung Cancer Surgery Market Size by Country (2025-2030) & (US$ Million) Table 45. China Lung Cancer Surgery Market Size by Type (2019-2024) & (US$ Million) Table 46. China Lung Cancer Surgery Market Size by Type (2025-2030) & (US$ Million) Table 47. China Lung Cancer Surgery Market Size by Application (2019-2024) & (US$ Million) Table 48. China Lung Cancer Surgery Market Size by Application (2025-2030) & (US$ Million) Table 49. Asia Lung Cancer Surgery Market Size by Type (2019-2024) & (US$ Million) Table 50. Asia Lung Cancer Surgery Market Size by Type (2025-2030) & (US$ Million) Table 51. Asia Lung Cancer Surgery Market Size by Application (2019-2024) & (US$ Million) Table 52. Asia Lung Cancer Surgery Market Size by Application (2025-2030) & (US$ Million) Table 53. Asia Lung Cancer Surgery Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 54. Asia Lung Cancer Surgery Market Size by Region (2019-2024) & (US$ Million) Table 55. Asia Lung Cancer Surgery Market Size by Region (2025-2030) & (US$ Million) Table 56. Middle East, Africa, and Latin America Lung Cancer Surgery Market Size by Type (2019-2024) & (US$ Million) Table 57. Middle East, Africa, and Latin America Lung Cancer Surgery Market Size by Type (2025-2030) & (US$ Million) Table 58. Middle East, Africa, and Latin America Lung Cancer Surgery Market Size by Application (2019-2024) & (US$ Million) Table 59. Middle East, Africa, and Latin America Lung Cancer Surgery Market Size by Application (2025-2030) & (US$ Million) Table 60. Middle East, Africa, and Latin America Lung Cancer Surgery Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 61. Middle East, Africa, and Latin America Lung Cancer Surgery Market Size by Country (2019-2024) & (US$ Million) Table 62. Middle East, Africa, and Latin America Lung Cancer Surgery Market Size by Country (2025-2030) & (US$ Million) Table 63. Accuray Company Details Table 64. Accuray Business Overview Table 65. Accuray Lung Cancer Surgery Product Table 66. Accuray Revenue in Lung Cancer Surgery Business (2019-2024) & (US$ Million) Table 67. Accuray Recent Developments Table 68. Angiodynamics Company Details Table 69. Angiodynamics Business Overview Table 70. Angiodynamics Lung Cancer Surgery Product Table 71. Angiodynamics Revenue in Lung Cancer Surgery Business (2019-2024) & (US$ Million) Table 72. Angiodynamics Recent Developments Table 73. Ethicon Company Details Table 74. Ethicon Business Overview Table 75. Ethicon Lung Cancer Surgery Product Table 76. Ethicon Revenue in Lung Cancer Surgery Business (2019-2024) & (US$ Million) Table 77. Ethicon Recent Developments Table 78. Intuitive Surgical Company Details Table 79. Intuitive Surgical Business Overview Table 80. Intuitive Surgical Lung Cancer Surgery Product Table 81. Intuitive Surgical Revenue in Lung Cancer Surgery Business (2019-2024) & (US$ Million) Table 82. Intuitive Surgical Recent Developments Table 83. Olympus Company Details Table 84. Olympus Business Overview Table 85. Olympus Lung Cancer Surgery Product Table 86. Olympus Revenue in Lung Cancer Surgery Business (2019-2024) & (US$ Million) Table 87. Olympus Recent Developments Table 88. Teleflex Company Details Table 89. Teleflex Business Overview Table 90. Teleflex Lung Cancer Surgery Product Table 91. Teleflex Revenue in Lung Cancer Surgery Business (2019-2024) & (US$ Million) Table 92. Teleflex Recent Developments Table 93. Ackermann Instrumente Company Details Table 94. Ackermann Instrumente Business Overview Table 95. Ackermann Instrumente Lung Cancer Surgery Product Table 96. Ackermann Instrumente Revenue in Lung Cancer Surgery Business (2019-2024) & (US$ Million) Table 97. Ackermann Instrumente Recent Developments Table 98. Karl Storz Company Details Table 99. Karl Storz Business Overview Table 100. Karl Storz Lung Cancer Surgery Product Table 101. Karl Storz Revenue in Lung Cancer Surgery Business (2019-2024) & (US$ Million) Table 102. Karl Storz Recent Developments Table 103. Scanlan International Company Details Table 104. Scanlan International Business Overview Table 105. Scanlan International Lung Cancer Surgery Product Table 106. Scanlan International Revenue in Lung Cancer Surgery Business (2019-2024) & (US$ Million) Table 107. Scanlan International Recent Developments Table 108. Trokamed Company Details Table 109. Trokamed Business Overview Table 110. Trokamed Lung Cancer Surgery Product Table 111. Trokamed Revenue in Lung Cancer Surgery Business (2019-2024) & (US$ Million) Table 112. Trokamed Recent Developments Table 113. Research Programs/Design for This Report Table 114. Key Data Information from Secondary Sources Table 115. Key Data Information from Primary Sources List of Figures Figure 1. Global Lung Cancer Surgery Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million) Figure 2. Global Lung Cancer Surgery Market Share by Type: 2023 VS 2030 Figure 3. Surgical Instruments Features Figure 4. Monitoring And Visualization System Features Figure 5. Global Lung Cancer Surgery Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million) Figure 6. Global Lung Cancer Surgery Market Share by Application: 2023 VS 2030 Figure 7. Lobectomy Case Studies Figure 8. Removal Of Sleeve Case Studies Figure 9. Regional Excision Case Studies Figure 10. Lung Removed All Case Studies Figure 11. Minimally Invasive Surgery Case Studies Figure 12. Lung Cancer Surgery Report Years Considered Figure 13. Global Lung Cancer Surgery Market Size (US$ Million), Year-over-Year: 2019-2030 Figure 14. Global Lung Cancer Surgery Market Size, (US$ Million), 2019 VS 2023 VS 2030 Figure 15. Global Lung Cancer Surgery Market Share by Region: 2023 VS 2030 Figure 16. Global Lung Cancer Surgery Market Share by Players in 2023 Figure 17. Global Top Lung Cancer Surgery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Surgery as of 2023) Figure 18. The Top 10 and 5 Players Market Share by Lung Cancer Surgery Revenue in 2023 Figure 19. North America Lung Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million) Figure 20. North America Lung Cancer Surgery Market Share by Type (2019-2030) Figure 21. North America Lung Cancer Surgery Market Share by Application (2019-2030) Figure 22. North America Lung Cancer Surgery Market Share by Country (2019-2030) Figure 23. United States Lung Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million) Figure 24. Canada Lung Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million) Figure 25. Europe Lung Cancer Surgery Market Size YoY (2019-2030) & (US$ Million) Figure 26. Europe Lung Cancer Surgery Market Share by Type (2019-2030) Figure 27. Europe Lung Cancer Surgery Market Share by Application (2019-2030) Figure 28. Europe Lung Cancer Surgery Market Share by Country (2019-2030) Figure 29. Germany Lung Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million) Figure 30. France Lung Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million) Figure 31. U.K. Lung Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million) Figure 32. Italy Lung Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million) Figure 33. Russia Lung Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million) Figure 34. Nordic Countries Lung Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million) Figure 35. China Lung Cancer Surgery Market Size YoY (2019-2030) & (US$ Million) Figure 36. China Lung Cancer Surgery Market Share by Type (2019-2030) Figure 37. China Lung Cancer Surgery Market Share by Application (2019-2030) Figure 38. Asia Lung Cancer Surgery Market Size YoY (2019-2030) & (US$ Million) Figure 39. Asia Lung Cancer Surgery Market Share by Type (2019-2030) Figure 40. Asia Lung Cancer Surgery Market Share by Application (2019-2030) Figure 41. Asia Lung Cancer Surgery Market Share by Region (2019-2030) Figure 42. Japan Lung Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million) Figure 43. South Korea Lung Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million) Figure 44. China Taiwan Lung Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million) Figure 45. Southeast Asia Lung Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million) Figure 46. India Lung Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million) Figure 47. Australia Lung Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million) Figure 48. Middle East, Africa, and Latin America Lung Cancer Surgery Market Size YoY (2019-2030) & (US$ Million) Figure 49. Middle East, Africa, and Latin America Lung Cancer Surgery Market Share by Type (2019-2030) Figure 50. Middle East, Africa, and Latin America Lung Cancer Surgery Market Share by Application (2019-2030) Figure 51. Middle East, Africa, and Latin America Lung Cancer Surgery Market Share by Country (2019-2030) Figure 52. Brazil Lung Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million) Figure 53. Mexico Lung Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million) Figure 54. Turkey Lung Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million) Figure 55. Saudi Arabia Lung Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million) Figure 56. Israel Lung Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million) Figure 57. GCC Countries Lung Cancer Surgery Market Size YoY Growth (2019-2030) & (US$ Million) Figure 58. Accuray Revenue Growth Rate in Lung Cancer Surgery Business (2019-2024) Figure 59. Angiodynamics Revenue Growth Rate in Lung Cancer Surgery Business (2019-2024) Figure 60. Ethicon Revenue Growth Rate in Lung Cancer Surgery Business (2019-2024) Figure 61. Intuitive Surgical Revenue Growth Rate in Lung Cancer Surgery Business (2019-2024) Figure 62. Olympus Revenue Growth Rate in Lung Cancer Surgery Business (2019-2024) Figure 63. Teleflex Revenue Growth Rate in Lung Cancer Surgery Business (2019-2024) Figure 64. Ackermann Instrumente Revenue Growth Rate in Lung Cancer Surgery Business (2019-2024) Figure 65. Karl Storz Revenue Growth Rate in Lung Cancer Surgery Business (2019-2024) Figure 66. Scanlan International Revenue Growth Rate in Lung Cancer Surgery Business (2019-2024) Figure 67. Trokamed Revenue Growth Rate in Lung Cancer Surgery Business (2019-2024) Figure 68. Bottom-up and Top-down Approaches for This Report Figure 69. Data Triangulation Figure 70. Key Executives Interviewed
01. サンプル提供
ご購入前にサンプル(英語、日本語)が提供可能。
02. カスタマイズサービス
レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。
03. プロフェッショナルな日本語翻訳
AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。
04. 多言語コミュニケーション
日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。
05. お支払方法
銀行振込(納品後、ご請求書送付)。
06. アフターサービス
ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。
請求書払いの場合:
レポート選択
見積もり依頼
メールでのご注文
入手(英語版は2〜4営業日、日本語版は8〜10営業日)
決済(後払い)
クレジットカード決済の場合:
レポート選択
ウェブサイトでのご注文
決済
入手(英語版は2〜4営業日、日本語版は8〜10営業日)